These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6695905)

  • 1. Assessing the validity of observed cancer incidence trends.
    Devesa SS; Pollack ES; Young JL
    Am J Epidemiol; 1984 Feb; 119(2):274-91. PubMed ID: 6695905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence and mortality trends among whites in the United States, 1947-84.
    Devesa SS; Silverman DT; Young JL; Pollack ES; Brown CC; Horm JW; Percy CL; Myers MH; McKay FW; Fraumeni JF
    J Natl Cancer Inst; 1987 Oct; 79(4):701-70. PubMed ID: 3309421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates.
    Frey CM; McMillen MM; Cowan CD; Horm JW; Kessler LG
    J Natl Cancer Inst; 1992 Jun; 84(11):872-7. PubMed ID: 1593655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current thyroid cancer trends in the United States.
    Davies L; Welch HG
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):317-22. PubMed ID: 24557566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for Cancer Incidence and Mortality - United States, 2013.
    Singh SD; Henley SJ; Ryerson AB
    MMWR Surveill Summ; 2017 Jan; 66(4):1-36. PubMed ID: 28125567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of death certificate errors on cancer mortality trends.
    Hoel DG; Ron E; Carter R; Mabuchi K
    J Natl Cancer Inst; 1993 Jul; 85(13):1063-8. PubMed ID: 8515493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.
    Henley SJ; Anderson RN; Thomas CC; Massetti GM; Peaker B; Richardson LC
    MMWR Surveill Summ; 2017 Jul; 66(14):1-13. PubMed ID: 28683054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating cancer mortality rates from SEER incidence and survival data.
    Chu KC; Horm JW; Smart CR
    Public Health Rep; 1990; 105(1):36-46. PubMed ID: 2106703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in cancer mortality in 15 industrialized countries, 1969-1986.
    Hoel DG; Davis DL; Miller AB; Sondik EJ; Swerdlow AJ
    J Natl Cancer Inst; 1992 Mar; 84(5):313-20. PubMed ID: 1738181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mesothelioma surveillance: a comparison of ICD 10 mortality data with SEER incidence data in nine areas of the United States.
    Pinheiro GA; Antao VC; Bang KM; Attfield MD
    Int J Occup Environ Health; 2004; 10(3):251-5. PubMed ID: 15473077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Dimitrova N; Parkin DM
    Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National cancer mortality and incidence in Japan.
    Kurihara M
    Environ Health Perspect; 1979 Oct; 32():59-74. PubMed ID: 540607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for Cancer Incidence and Mortality - United States, 2012.
    Singh SD; Henley SJ; Ryerson AB
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 63(55):17-58. PubMed ID: 27736826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79.
    Ries LG; Pollack ES; Young JL
    J Natl Cancer Inst; 1983 Apr; 70(4):693-707. PubMed ID: 6572758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.